Exploring the Effect of Previous Inactivated Influenza Vaccination on Seasonal Influenza Vaccine Effectiveness against Medically Attended Influenza: Results of the European I-MOVE Multicentre Test-Negative Case-Control Study, 2011/2012-2016/2017
Autor: | Valenciano, M, Kissling, E, Larrauri, A, Nunes, B, Pitigoi, D, O'Donnell, J, Reuss, A, Horváth, Jk, Paradowska-Stankiewicz, I, Rizzo, C, Falchi, A, Daviaud, I, Brytting, M, Meijer, A, Kaic, B, Gherasim, A, Machado, A, Ivanciuc, A, Domegan, L, Schweiger, B, Ferenczi, A, Korczyńska, M, Bella, A, Vilcu, Am, Mosnier, A, Zakikhany, K, de Lange, M, Kurečić Filipovićović, S, Johansen, K, Moren, A, I-MOVE primary care multicentre case-control, Team. |
---|---|
Přispěvatelé: | EpiConcept [Paris], Institute of Health Carlos III, Instituto Nacional de Saùde Dr Ricardo Jorge [Portugal] (INSA), University of Medicine and Pharmacy 'Carol Davila' Bucharest (UMPCD), Cantacuzino Institute [Romania], Réseau International des Instituts Pasteur (RIIP), Health Protection Surveillance Centre (HPSC), Department for Infectious Disease Epidemiology [Berlin], Robert Koch Institute [Berlin] (RKI), National Centre for Epidemiology [Budapest], National Institute of Public Health - National Institute of Hygiene [Poland], Istituto Superiore di Sanita [Rome], Università di Corsica Pasquale Paoli [Université de Corse Pascal Paoli], Partenaires INRAE, Réseau des Groupes Régionaux d'Observation de la Grippe (GROG), Coordination nationale, Public Health Agency of Sweden, National Institute for Public Health and the Environment [Bilthoven] (RIVM), Croatian Institute of Public Health [Zagreb] (CIPH), Instituto Superiore di Sanità (ISS), Institut Pierre Louis d'Epidémiologie et de Santé Publique (iPLESP), Institut National de la Santé et de la Recherche Médicale (INSERM)-Sorbonne Université (SU), European Centre for Disease Prevention and Control (ECDC), Gestionnaire, HAL Sorbonne Université 5 |
Jazyk: | angličtina |
Rok vydání: | 2018 |
Předmět: |
Infecções Respiratórias
Male 0301 basic medicine Epidemiology [SDV]Life Sciences [q-bio] Efetividade da Vacina Antigripal Influenza vaccinations Seasonal influenza 0302 clinical medicine Previous Vaccination Medicine 030212 general & internal medicine Child Prospective cohort study Vaccine effectiveness Aged 80 and over education.field_of_study Influenza vaccine IMOVE virus diseases Case-control study Middle Aged multicentre study 3. Good health Vaccination [SDV] Life Sciences [q-bio] Treatment Outcome Infectious Diseases Influenza Vaccines Original Article Female influenza Adult Pulmonary and Respiratory Medicine Adolescent case-control study 030106 microbiology Population Multicentre study Young Adult 03 medical and health sciences Influenza Human Humans Vacina Antigripal education Aged vaccine effectiveness case‐control study business.industry Cuidados de Saúde Public Health Environmental and Occupational Health Original Articles Estados de Saúde e de Doença Influenza Negative case Determinantes da Saúde e da Doença influenza vaccine business Demography |
Zdroj: | Influenza and Other Respiratory Viruses Influenza and Other Respiratory Viruses, 2018, 12 (5), pp.567--581. ⟨10.1111/irv.12562⟩ Repisalud Instituto de Salud Carlos III (ISCIII) |
Popis: | Free PMC Article: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6086844/ I‐MOVE primary care multicentre case‐control team - Portugal: Baltazar Nunes, Ausenda Machado, Ana Paula Rodrigues, Verónica Gomez (Departamento de Epidemiologia, Instituto Nacional de Saúde Dr. Ricardo Jorge); Raquel Guiomar, Pedro Pechirra, Paula Cristóvão, Patrícia Conde, Inês Costa (Departamento de Doenças Infeciosas, Instituto Nacional de Saúde Dr. Ricardo Jorge) BACKGROUND: Results of previous influenza vaccination effects on current season influenza vaccine effectiveness (VE) are inconsistent. OBJECTIVES: To explore previous influenza vaccination effects on current season VE among population targeted for vaccination. METHODS: We used 2011/2012 to 2016/2017 I-MOVE primary care multicentre test-negative data. For each season, we compared current season adjusted VE (aVE) between individuals vaccinated and unvaccinated in previous season. Using unvaccinated in both seasons as a reference, we then compared aVE between vaccinated in both seasons, current only, and previous only. RESULTS: We included 941, 2645 and 959 influenza-like illness patients positive for influenza A(H1N1)pdm09, A(H3N2) and B, respectively, and 5532 controls. In 2011/2012, 2014/2015 and 2016/2017, A(H3N2) aVE point estimates among those vaccinated in previous season were -68%, -21% and -19%, respectively; among unvaccinated in previous season, these were 33%, 48% and 46%, respectively (aVE not computable for influenza A(H1N1)pdm09 and B). Compared to current season vaccination only, VE for both seasons' vaccination was (i) similar in two of four seasons for A(H3N2) (absolute difference [ad] 6% and 8%); (ii) lower in three of four seasons for influenza A(H1N1)pdm09 (ad 18%, 26% and 29%), in two seasons for influenza A(H3N2) (ad 27% and 39%) and in two of three seasons for influenza B (ad 26% and 37%); (iii) higher in one season for influenza A(H1N1)pdm09 (ad 20%) and influenza B (ad 24%). CONCLUSIONS: We did not identify any pattern of previous influenza vaccination effect. Prospective cohort studies documenting influenza infections, vaccinations and vaccine types are needed to understand previous influenza vaccinations' effects. European Centre for Disease Prevention and Control. Grant Number: ECDC/2014/026 European Union's Horizon 2020 research and innovation programme. Grant Number: 634446 WHO‐EURO info:eu-repo/semantics/publishedVersion |
Databáze: | OpenAIRE |
Externí odkaz: |